Strengthens and expands U.S. biosimilars immunology portfolio with multi-indication arthritis treatment “Biosimilars continue to be a key growth driver for Organon, and this acquisition complements ...
Findings showed tocilizumab-anoh had comparable efficacy, pharmacokinetics, safety, and immunogenicity with Actemra. The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a ...
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
The SC formulation is now available in a prefilled syringe and an autoinjector. Tyenne ® (tocilizumab-aazg), a biosimilar to Actemra ® (tocilizumab), is now available in a subcutaneous (SC) ...
The Maharashtra FDA has submitted reports about adequate availability of hydroxychloroquine (HCQ) tablets, remdesivir and tocilizumab injections to the Central Drugs Standard Control Organisation ...
Long-term treatment with tocilizumab was effective in patients with moderate-to-severe thyroid eye disease (TED) that was resistant to corticosteroids, with 58% of patients achieving clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results